Loading...

Roivant Sciences Ltd.

ROIV•NASDAQ
Healthcare
Biotechnology
$27.41
$-0.73(-2.59%)
U.S. Market opens in 49h 27m

Roivant Sciences Ltd. (ROIV) Stock Overview

Explore Roivant Sciences Ltd.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap19.6B
P/E Ratio-23.49
EPS (TTM)$-1.17
ROE-0.18%
Fundamental Analysis

AI Price Forecasts

1 Month$28.28
3 Months$35.52
1 Year Target$33.96

ROIV Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Roivant Sciences Ltd. (ROIV) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 43.46, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $33.96.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -23.49 and a market capitalization of 19.6B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-2.59%
5-Day Change
-7.21%
1-Month Change
2.010%
3-Month Change
21.39%
6-Month Change
50.44%
Year-to-Date (YTD) Change
26.31%
1-Year Change
149.18%
3-Year Change
209.02%
5-Year Change
179.41%
All-Time (Max) Change
163.56%

Contact Information

https://roivant.com
44 2074 003 347
11-12 St. James's Square, London, NaN, SW1Y 4LB

Company Facts

908 Employees
IPO DateDec 8, 2020
CountryGB
Actively Trading

Frequently Asked Questions